版本:
中国

BRIEF-Biocept, Catalyst Pharma to provide liquid biopsy testing for small cell lung cancer

March 14 Biocept Inc:

* Biocept and Catalyst Pharmaceuticals collaborate to provide liquid biopsy testing for small cell lung cancer to patients with Lambert Eaton Myasthenic Syndrome (LEMS)

* Biocept Inc- terms of agreement were not disclosed Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐